F2R and gastric cancer: Given that PAR-1 can activate phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling 13-18, it was speculated that the PI3K/Akt pathway could be a possible downstream target of ncRuPAR and this study explored their relationship in gastric cancer.